Cassady Schiller Wealth Management’s United Therapeutics UTHR Stock Holding History

Cassady Schiller Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.06K	Buy	+3	New	+$1.1K	﹤0.01%	776

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Cassady Schiller Wealth Management's UTHR Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in United Therapeutics (UTHR) in Q4 2024: 3 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #776 among its holdings.

672 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

Cassady Schiller Wealth Management held 3 shares of United Therapeutics worth $1.06K as of Q4 2024.
United Therapeutics was a new Cassady Schiller Wealth Management position in Q4 2024.
United Therapeutics made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #776 holding.
672 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.